Biochip for detecting myocardial infarction marker, and detection method applying same

Abstract

The invention relates to a biochip for detecting a myocardial infarction marker, and belongs to the technical field of POCT detection. The biochip comprises biosensors, which are a wafer platform anda spotted antibody coated on the wafer platform, wherein the spotted antibody can form an immune complex with a magnetic bead conjugated antibody and the marker protein, and complex aggregation of magnetic beads will be formed on the biosensor coated with the spotted antibody when the blood sample contains the myocardial infarction marker protein. In the technical solution, the magnetic beads havea large specific surface area, and more antibodies are combined to improve the sensitivity of the detection; at the same time, the biomolecules and proteins are not magnetic, the magnetic beads not bound to the sensor cannot excite the magnetic field to generate magnetic resistance signals, and the specificity is high than the traditional chemiluminescence method. The invention also provides a detection method for applying the biochip, which can realize micro-measurement and micro-detection, and shortens the diagnosis time by controlling the detection time of 15 minutes to 20 minutes.

Description

technical field [0001] The invention relates to a biochip, which is mainly used for detecting the detection of myocardial infarction markers in blood samples. The invention also provides a detection method using the biochip, which belongs to the technical field of POCT detection. Background technique [0002] Cardiovascular disease is a serious disease that endangers human health and life, and has become the number one killer of human health in the 21st century. According to the "China Cardiovascular Disease Report 2015" and "China Cardiovascular Disease Report 2016" compiled by the National Center for Cardiovascular Diseases, the number of patients with cardiovascular diseases in my country is still growing rapidly. According to statistics, the number of patients with cardiovascular disease was 290 million in 2014, and this number has climbed to 290 million by 2015. According to the report estimates, about 3.5 million people die of cardiovascular disease in my country ever...

AI Technical Summary

Problems solved by technology

[0008] The first-generation detection technology competition method (radioimmunoassay, RIA): There are many factors affected, and the RIA sample requires a large amount. Because extraction is usually required before detection, it not only increases the operation steps, but also because the recovery rate of extraction is usually Only 80% to 90%, the coefficient of variation (CV) is relatively large, which reduces the precision of detection;

[0009] The second-generation detection method non-competitive method (radioimmunoassay, RIA): immunoassay using double-antibody sandwich, no extraction, high antibody specificity, its sensitivity, precision and specificity are better than competitive methods, but time-consuming Still long and difficult to apply to automation;

[0010] The third-generation detection method enzyme immunoassay, stationary phase immunochromatography: the double antibody plus core method immunoassay solid phase chromatography includes colloidal gold, immunofluorescence, etc., the antibody specificity is high, its sensitivity, precision and The specificity is better than the non-competitive method, which can realize semi-automatic detection of equipment detection, and can only realize quantitative / semi-quantitative detection. The operation, samples and physical properties have a great influence on the sensitivity of the detection characteristics, and there is a large inter-batch difference and variation The coefficient is generally 15% to 30%;

However, this detection method still has the following shortcomings: optical background noise, sample photobleaching, and optical signal attenuation will interfere with the sensitivity and specificity of the detection. At the same time, the equipment cannot be miniaturized and POCT, and it is mainly operated by professionals. , unable to achieve bedside detection, ambulance detection and home detection

Images